期刊文献+

胰腺癌患者血清CEACAM1的测定及其诊断价值 被引量:12

Diagnostic value of serum CEACAM1 in patients with pancreatic cancer
下载PDF
导出
摘要 目的研究肿瘤标志物CEACAM1对胰腺癌诊断价值。方法收集南方医院、珠江医院和佛山市第一人民医院2008年1月-2009年10月住院胰腺癌病人50例和慢性胰腺炎对照50例;采用ELISA测定各组患者血清CEACAMl水平;根据ROC曲线中敏感性和特异性之和最高点为参考,制定CEACAMl的截断值并计算ROC曲线下面积;根据肿瘤标志物诊断效率评估表评价各个肿瘤标志物对胰腺癌诊断效率。 Objective To investigate the diagnostic value of serum CEACAM1 in patients with pancreatic cancer. Methods Fifty patients with pancreatic cancer and 50 with chronic pancreatitis were examine for serum levels of CEACAM1 by enzyme-linked immunosorbent assay (ELISA).
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第1期164-166,共3页 Journal of Southern Medical University
关键词 CEACAM1 CA19-9 CA242 胰腺癌 CEACAM1 CA19-9 CA242 pancreatic cancer
  • 相关文献

参考文献11

  • 1Gattani AM, Mandeli J, Bruekener HW. Tumor markers in patients with pancreatic carcinoma[J]. Cancer, 1996, 78(1): 57-62. 被引量:1
  • 2Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer [ J ]. J Clin Oncol, 2006, 24(33): 5313-27. 被引量:1
  • 3Simeone DM, Ji B, Banerjee M, et al. CEACAM1, a novel serum biomarker for pancreatic cancer[ J ]. Pancreas, 2007, 36(4): 436-43. 被引量:1
  • 4宋花玲,贺佳,虞慧婷,李玲.应用ROC曲线下面积对两相关诊断试验进行评价和比较[J].第二军医大学学报,2006,27(5):562-563. 被引量:72
  • 5Me Langwlin RO, Hanlon D, Kerin M, et al. Are elevated levels of the tumour mrker CA19-9 of any significance?-an evaluation [J]. Ir J Med Sci, 1999, 168(2): 124-6. 被引量:1
  • 6Serra S, Asa SL, Bamberger AM, et al. CEACAM1 expression in pancreatic endocrine tumors [J]. Appl Immunohistochem Mol Morphol, 2009, 17(4): 286-93. 被引量:1
  • 7Obrink B. On the role of CEACAM1 in cancer[J]. Lung Cancer, 2008, 60(3): 309-12. 被引量:1
  • 8Samsen A, Bogoevska V, Klampe B, et al. DC-SIGN and SRCL bind glycans of carcinoembryonic antigen (CEA) and CEA-related cell adhesion molecule 1 (CEACAM1): recombinant human glycan-binding receptors as analytical tools [J]. Eur J Cell Biol, 2010, 89(1): 87-94. 被引量:1
  • 9Chaturvedi P, Singh AP, Moniaux N, et al. MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins[J]. Mol Cancer Res, 2007, 5(4): 309-20. 被引量:1
  • 10姚家奎,柏斗胜.联合检测癌胚抗原相关细胞黏附分子1和人糖链抗原19-9早期诊断胰腺癌的临床研究[J].中国临床医学,2009,16(6):880-881. 被引量:5

二级参考文献11

  • 1Jemal A,Murray T,Ward E,et al. Cancer statistics[J].2005,CA Cancer J Clin,2005,55 : 10-30. 被引量:1
  • 2Niederau C,Grendell JH. Diagnosis of pancreatic cancer. Ima ging studies and tumor markers[J]. Pancreas, 1992,7(10):66 -86. 被引量:1
  • 3DiMagno EP,Reber HA,Tempuro MA. AGA technical review on epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association[J]. Gastroenterology, 1999,117 : 1464-1484. 被引量:1
  • 4Pasanen PA, Eskelinen M, Partanen K, et at. Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA,CA50 and CA242 in pancreatic cancer,results from a prospective study [J].Br J Cancer, 1993.67(4).852- 855. 被引量:1
  • 5Ozkan H, Kaya M, Cengiz A. Comparison of tumor marker CA242 with CA19 9 and carcinoernbryonic antigen (CEA) in pancreatic cancer [J]. Hepatogastroenterology, 2003,50 ( 53 ) :1669 -1674. 被引量:1
  • 6Diane MS,Baoan JI,Mousumi B,et al. CEACAM1 ,a Novel Serum biomarker for pancreatic cancer[J].Pancreas, 2007,4( 34): 436-444. 被引量:1
  • 7DeLong ER,DeLong DM,Clarke-Pearson DL.Comparing the areas under two or more correlated receiver operating characteristic curves:a nonparametric approach[J].Biometrics,1988,44:837-845. 被引量:1
  • 8Zhou X,Obuchowski NA,Mcclish DK.Statistical methods in diagnostic medicine[M].New York:Wiley,2002:111-136,180-187. 被引量:1
  • 9刘天佑,丁丽楠,王璟瑞,梁桃.胰液K-ras12密码子点突变联合胰液CA19-9水平与胰腺癌的复发关系[J].中国临床医学,2008,15(3):358-359. 被引量:2
  • 10傅德良,倪泉兴.胰腺癌的早期诊断和治疗进展[J].中国临床医学杂志,2000,7(1):107-109. 被引量:4

共引文献74

同被引文献94

引证文献12

二级引证文献71

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部